Avalo TherapeuticsAVTX
13F holders, Q2 2026 (June 30)1holders
$18.48avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Avalo Therapeutics Inc. (AVTX) in their 13F filings. The largest holder was Byrne Asset Management LLC ($89K).
- Company
- Avalo Therapeutics Inc.
- CUSIP
- 00750Y206
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $89K |
| Exits | 0 | $0 |
Ownership 1 holders
| Byrne Asset Management LLC | 0.05% | New | 4,798 | $89K |
"% of holder's portfolio" is AVTX's weight in each manager's 13F, not the share of Avalo Therapeutics Inc. the manager owns.